1. Home
  2. DSX vs TLSI Comparison

DSX vs TLSI Comparison

Compare DSX & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.73

Market Cap

273.7M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$4.93

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
TLSI
Founded
1999
2010
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
270.2M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
DSX
TLSI
Price
$2.73
$4.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
911.8K
173.0K
Earning Date
05-28-2026
05-12-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$45,151,000.00
Revenue This Year
$14.28
$35.45
Revenue Next Year
$4.87
$37.58
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
53.41
52 Week Low
$1.57
$2.20
52 Week High
$2.92
$7.95

Technical Indicators

Market Signals
Indicator
DSX
TLSI
Relative Strength Index (RSI) 64.34 50.03
Support Level $2.27 $4.21
Resistance Level $2.90 $5.58
Average True Range (ATR) 0.09 0.30
MACD 0.01 -0.09
Stochastic Oscillator 86.73 21.89

Price Performance

Historical Comparison
DSX
TLSI

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: